BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17883917)

  • 1. Skin testing and adverse reactions in fluorescein: a prospective study.
    Kalogeromitros DC; Makris MP; Rouvas A; Theodossiadis PG; Spanoudaki N; Papaioannou D
    Allergy Asthma Proc; 2007; 28(4):472-6. PubMed ID: 17883917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergy skin testing in predicting adverse reactions to fluorescein: a prospective clinical study.
    Kalogeromitros DC; Makris MP; Aggelides XS; Mellios AI; Giannoula FC; Sideri KA; Rouvas AA; Theodossiadis PG
    Acta Ophthalmol; 2011 Aug; 89(5):480-3. PubMed ID: 19906081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein-induced allergic reaction.
    López-Sáez MP; Ordoqui E; Tornero P; Baeza A; Sainza T; Zubeldia JM; Baeza ML
    Ann Allergy Asthma Immunol; 1998 Nov; 81(5):428-30. PubMed ID: 9860035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of radiocontrast media skin tests as a prescreening and diagnostic tool in hypersensitivity reactions.
    Kim SH; Jo EJ; Kim MY; Lee SE; Kim MH; Yang MS; Song WJ; Choi SI; Kim JH; Chang YS
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):258-62. PubMed ID: 23535089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with penicillin skin testing in a large inner-city STD clinic.
    Gadde J; Spence M; Wheeler B; Adkinson NF
    JAMA; 1993 Nov; 270(20):2456-63. PubMed ID: 8230623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience.
    Kwan AS; Barry C; McAllister IL; Constable I
    Clin Exp Ophthalmol; 2006; 34(1):33-8. PubMed ID: 16451256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of sodium fluorescein for in vivo study of skin.
    O'goshi K; Serup J
    Skin Res Technol; 2006 Aug; 12(3):155-61. PubMed ID: 16827689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of the prick test for anaphylactoid reaction in intravenous fluorescein administration].
    Matsuura M; Ando F; Fukumoto K; Kyogane I; Torii Y; Matsuura M
    Nippon Ganka Gakkai Zasshi; 1996 Apr; 100(4):313-7. PubMed ID: 8644545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reaction in patients with drug allergy history after simultaneous intravenous fundus fluorescein angiography and indocyanine green angiography.
    Su Z; Ye P; Teng Y; Zhang L; Shu X
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):410-3. PubMed ID: 22372690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse reactions during fluorescence fundus angiography in special patients].
    Su ZA; Zhang LX; Teng Y
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(21):1490-2. PubMed ID: 19953903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiocontrast media-associated exanthema: identification of cross-reactivity and tolerability by allergologic testing.
    Seitz CS; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Eur J Radiol; 2009 Oct; 72(1):167-71. PubMed ID: 18620831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
    Paranos S; Petrović S; Vojović I
    Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sodium fluorescein solution for detection of cerebrospinal fluid fistulas: an analysis of 420 administrations and reported complications in Europe and the United States.
    Keerl R; Weber RK; Draf W; Wienke A; Schaefer SD
    Laryngoscope; 2004 Feb; 114(2):266-72. PubMed ID: 14755201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity to therapeutic murine monoclonal antibodies.
    Kornbrot B; Kobayashi RH; Singer A; Tempero MA; Heiner DC
    Nebr Med J; 1994 Dec; 79(12):393-8. PubMed ID: 7870212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study.
    Brockow K; Romano A; Aberer W; Bircher AJ; Barbaud A; Bonadonna P; Faria E; Kanny G; Lerch M; Pichler WJ; Ring J; Rodrigues Cernadas J; Tomaz E; Demoly P; Christiansen C;
    Allergy; 2009 Feb; 64(2):234-41. PubMed ID: 19178403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults.
    Sogn DD; Evans R; Shepherd GM; Casale TB; Condemi J; Greenberger PA; Kohler PF; Saxon A; Summers RJ; VanArsdel PP
    Arch Intern Med; 1992 May; 152(5):1025-32. PubMed ID: 1580706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of patch and challenge tests in the diagnosis of cell-mediated allergy to betalactams.
    Patriarca G; D'Ambrosio C; Schiavino D; Larocca LM; Nucera E; Milani A
    Ann Allergy Asthma Immunol; 1999 Sep; 83(3):257-66. PubMed ID: 10507273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology].
    Ruëff F; Bergmann KC; Brockow K; Fuchs T; Grübl A; Jung K; Klimek L; Müsken H; Pfaar O; Przybilla B; Sitter H; Wehrmann W;
    Pneumologie; 2011 Aug; 65(8):484-95. PubMed ID: 21830178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications of lumbar administration of 5% sodium fluorescein solution for detection of cerebrospinal fluid fistula].
    Keerl R; Weber RK; Draf W; Radziwill R; Wienke A
    Laryngorhinootologie; 2003 Dec; 82(12):833-8. PubMed ID: 14755368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous adverse drug reactions: enhanced imputation score by skin testing].
    Choquet-Kastylevsky G; Vial T; Santolaria N; Nageotte A; Faure M; Claudy A; Descotes J
    Ann Dermatol Venereol; 2001 Apr; 128(4):507-11. PubMed ID: 11395648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.